date: 2013-11-28T08:34:20Z
pdf:PDFVersion: 1.4
pdf:docinfo:title: Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara
xmp:CreatorTool: PScript5.dll Version 5.2.2
access_permission:can_print_degraded: true
subject: The production of several viral vaccines depends on chicken embryo fibroblasts or embryonated chicken eggs. To replace this logistically demanding substrate, we created continuous anatine suspension cell lines (CR and CR.pIX), developed chemically-defined media, and established production processes for different vaccine viruses. One of the processes investigated in greater detail was developed for modified vaccinia virus Ankara (MVA). MVA is highly attenuated for human recipients and an efficient vector for reactogenic expression of foreign genes. Because direct cell-to-cell spread is one important mechanism for vaccinia virus replication, cultivation of MVA in bioreactors is facilitated if cell aggregates are induced after infection. This dependency may be the mechanism behind 
our observation that a novel viral genotype (MVA-CR) accumulates with serial passage in suspension cultures. Sequencing of a major part of the genomic DNA of the new strain revealed point mutations in three genes. We hypothesize that these changes confer 
an advantage because they may allow a greater fraction of MVA-CR viruses to escape the host cells for infection of distant targets. Production and purification of MVA-based vaccines may be simplified by this combination of designed avian cell line, chemically defined media and the novel virus strain.

dc:format: application/pdf; version=1.4
pdf:docinfo:creator_tool: PScript5.dll Version 5.2.2
access_permission:fill_in_form: true
pdf:encrypted: false
dc:title: Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara
modified: 2013-11-28T08:34:20Z
cp:subject: The production of several viral vaccines depends on chicken embryo fibroblasts or embryonated chicken eggs. To replace this logistically demanding substrate, we created continuous anatine suspension cell lines (CR and CR.pIX), developed chemically-defined media, and established production processes for different vaccine viruses. One of the processes investigated in greater detail was developed for modified vaccinia virus Ankara (MVA). MVA is highly attenuated for human recipients and an efficient vector for reactogenic expression of foreign genes. Because direct cell-to-cell spread is one important mechanism for vaccinia virus replication, cultivation of MVA in bioreactors is facilitated if cell aggregates are induced after infection. This dependency may be the mechanism behind 
our observation that a novel viral genotype (MVA-CR) accumulates with serial passage in suspension cultures. Sequencing of a major part of the genomic DNA of the new strain revealed point mutations in three genes. We hypothesize that these changes confer 
an advantage because they may allow a greater fraction of MVA-CR viruses to escape the host cells for infection of distant targets. Production and purification of MVA-based vaccines may be simplified by this combination of designed avian cell line, chemically defined media and the novel virus strain.

pdf:docinfo:subject: The production of several viral vaccines depends on chicken embryo fibroblasts or embryonated chicken eggs. To replace this logistically demanding substrate, we created continuous anatine suspension cell lines (CR and CR.pIX), developed chemically-defined media, and established production processes for different vaccine viruses. One of the processes investigated in greater detail was developed for modified vaccinia virus Ankara (MVA). MVA is highly attenuated for human recipients and an efficient vector for reactogenic expression of foreign genes. Because direct cell-to-cell spread is one important mechanism for vaccinia virus replication, cultivation of MVA in bioreactors is facilitated if cell aggregates are induced after infection. This dependency may be the mechanism behind 
our observation that a novel viral genotype (MVA-CR) accumulates with serial passage in suspension cultures. Sequencing of a major part of the genomic DNA of the new strain revealed point mutations in three genes. We hypothesize that these changes confer 
an advantage because they may allow a greater fraction of MVA-CR viruses to escape the host cells for infection of distant targets. Production and purification of MVA-based vaccines may be simplified by this combination of designed avian cell line, chemically defined media and the novel virus strain.

pdf:docinfo:creator: Ingo Jordan
meta:author: Verena Lohr
meta:creation-date: 2013-11-01T14:36:35Z
created: 2013-11-01T14:36:35Z
access_permission:extract_for_accessibility: true
Creation-Date: 2013-11-01T14:36:35Z
Author: Verena Lohr
producer: Acrobat Distiller 9.0.0 (Windows)
pdf:docinfo:producer: Acrobat Distiller 9.0.0 (Windows)
pdf:unmappedUnicodeCharsPerPage: 0
dc:description: The production of several viral vaccines depends on chicken embryo fibroblasts or embryonated chicken eggs. To replace this logistically demanding substrate, we created continuous anatine suspension cell lines (CR and CR.pIX), developed chemically-defined media, and established production processes for different vaccine viruses. One of the processes investigated in greater detail was developed for modified vaccinia virus Ankara (MVA). MVA is highly attenuated for human recipients and an efficient vector for reactogenic expression of foreign genes. Because direct cell-to-cell spread is one important mechanism for vaccinia virus replication, cultivation of MVA in bioreactors is facilitated if cell aggregates are induced after infection. This dependency may be the mechanism behind 
our observation that a novel viral genotype (MVA-CR) accumulates with serial passage in suspension cultures. Sequencing of a major part of the genomic DNA of the new strain revealed point mutations in three genes. We hypothesize that these changes confer 
an advantage because they may allow a greater fraction of MVA-CR viruses to escape the host cells for infection of distant targets. Production and purification of MVA-based vaccines may be simplified by this combination of designed avian cell line, chemically defined media and the novel virus strain.

Keywords: AGE1.CR.pI; muscovy duck continuous cell line; modified vaccinia virus Ankara; MVA (modified vaccinia virus Ankara)
access_permission:modify_annotations: true
dc:creator: Verena Lohr
description: The production of several viral vaccines depends on chicken embryo fibroblasts or embryonated chicken eggs. To replace this logistically demanding substrate, we created continuous anatine suspension cell lines (CR and CR.pIX), developed chemically-defined media, and established production processes for different vaccine viruses. One of the processes investigated in greater detail was developed for modified vaccinia virus Ankara (MVA). MVA is highly attenuated for human recipients and an efficient vector for reactogenic expression of foreign genes. Because direct cell-to-cell spread is one important mechanism for vaccinia virus replication, cultivation of MVA in bioreactors is facilitated if cell aggregates are induced after infection. This dependency may be the mechanism behind 
our observation that a novel viral genotype (MVA-CR) accumulates with serial passage in suspension cultures. Sequencing of a major part of the genomic DNA of the new strain revealed point mutations in three genes. We hypothesize that these changes confer 
an advantage because they may allow a greater fraction of MVA-CR viruses to escape the host cells for infection of distant targets. Production and purification of MVA-based vaccines may be simplified by this combination of designed avian cell line, chemically defined media and the novel virus strain.

dcterms:created: 2013-11-01T14:36:35Z
Last-Modified: 2013-11-28T08:34:20Z
dcterms:modified: 2013-11-28T08:34:20Z
title: Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara
xmpMM:DocumentID: uuid:08eca8de-f217-4f81-a339-0f721e8ae751
Last-Save-Date: 2013-11-28T08:34:20Z
pdf:docinfo:keywords: AGE1.CR.pI; muscovy duck continuous cell line; modified vaccinia virus Ankara; MVA (modified vaccinia virus Ankara)
pdf:docinfo:modified: 2013-11-28T08:34:20Z
meta:save-date: 2013-11-28T08:34:20Z
Content-Type: application/pdf
X-Parsed-By: org.apache.tika.parser.DefaultParser
creator: Verena Lohr
dc:subject: AGE1.CR.pI; muscovy duck continuous cell line; modified vaccinia virus Ankara; MVA (modified vaccinia virus Ankara)
access_permission:assemble_document: true
xmpTPg:NPages: 22
pdf:charsPerPage: 2279
access_permission:extract_content: true
access_permission:can_print: true
meta:keyword: AGE1.CR.pI; muscovy duck continuous cell line; modified vaccinia virus Ankara; MVA (modified vaccinia virus Ankara)
access_permission:can_modify: true
pdf:docinfo:created: 2013-11-01T14:36:35Z